Nursing Follow up in Geriatric Oncology : Tracking Time of Caregiver Exhaustion Risk

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-31

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In geriatric oncology, caregivers are submitted to a risk of exhaustion. To investigate the clinical risk factor of exhaustion, the researchers propose to conduct a prospective observational study during 6 months phone follow up of the caregivers. The recruitment will take place during the oncogeriatric assessment consultation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment and Prevention of Caregiver Burden in Oncology

NCT05750836

Oncology Caregiver Burden

NOT_YET_RECRUITING NA

Implementation of a Return Home With a Hospitalization at Home or With a Home Health Care Provider From the Services of Oncopneumology, Oncology and Hematology of University Hospital of Strasbourg

NCT03217864

Cancer

UNKNOWN

Cancer Fatigue Education Program

NCT01278147

Patient With Histologically Confirmed Malignancy

COMPLETED NA

Place of Comprehensive Geriatric Assessment in Patients ≥ 75 Years Care, With Breast Cancer, After Screening With FOG (Oncology Geriatric Filter)

NCT03059875

Surgery 75 Years Old and More Female Breast Cancer

UNKNOWN NA

Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy

NCT02583035

Cancer Hematologic Malignancy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary purpose aim to describe the caregiver of patient with 70 years old or more, suffered from cancer and for which a treatment is planned, along with their long term evolution.

The secondary purposes are to :

* Assess the exhaustion level felt by this caregiver
* Assess the medium delay of caregiver exhaustion apparition
* Relate factors associated to the medium delay of caregiver exhaustion apparition during patient chemotherapy and/or radiotherapy treatment

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Exhaustion Geriatric Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caregiver of cancer patient followed in geriatric oncology

caregiver of cancer patient with 70 years old or more, for which a treatment is planned, along with their long term evolution

Group Type EXPERIMENTAL

Phone nursing follow-up

Intervention Type OTHER

From the day of geriatric cancer patient's consultation, nurses will identify caregiver and will follow them by phone (caregiver) during 6 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phone nursing follow-up

From the day of geriatric cancer patient's consultation, nurses will identify caregiver and will follow them by phone (caregiver) during 6 months

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Caregiver of :

* patient with 70 years old or more, suffered from cancer and receiving specific cancer treatment (chemotherapy or radiotherapy )
* Patient evaluated in a specific comprehensive oncogeriatric assessment
* informed patient given a non-opposition form
* Patient affiliated to a social protection scheme
* Informed consent given by the caregiver

Exclusion Criteria

* Patient and caregiver under judicial protection
* Caregiver with understanding difficulties with French language
* Psychological, familial, social or geographic conditions that avoid a good clinical trial continuity
* Patient with ≤ 18 years old
* Caregiver and patient with significant cognitive troubles
* Caregiver and patient located in institution during inclusion period

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes